Access to anti-retroviral drugs, female in Barbados
Barbados: Access to anti-retroviral drugs, female was 67.0% in 2024. ▲ Rising
Access to anti-retroviral drugs, female in Barbados, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Barbados is 67.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 1.5% on the previous year and up 34.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Barbados peaked at 67.0% in 2021 and was at its lowest, 0.0%, in 2000.
Barbados ranks 88th of 141 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Access to anti-retroviral drugs, female in Barbados, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 1.0% | — |
| 2003 | 19.0% | +1800.0% |
| 2004 | 23.0% | +21.1% |
| 2005 | 27.0% | +17.4% |
| 2006 | 29.0% | +7.4% |
| 2007 | 32.0% | +10.3% |
| 2008 | 35.0% | +9.4% |
| 2009 | 38.0% | +8.6% |
| 2010 | 41.0% | +7.9% |
| 2011 | 43.0% | +4.9% |
| 2012 | 46.0% | +7.0% |
| 2013 | 49.0% | +6.5% |
| 2014 | 50.0% | +2.0% |
| 2015 | 53.0% | +6.0% |
| 2016 | 54.0% | +1.9% |
| 2017 | 57.0% | +5.6% |
| 2018 | 59.0% | +3.5% |
| 2019 | 64.0% | +8.5% |
| 2020 | 65.0% | +1.6% |
| 2021 | 67.0% | +3.1% |
| 2022 | 64.0% | -4.5% |
| 2023 | 66.0% | +3.1% |
| 2024 | 67.0% | +1.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 20.4% | 0.0% | 38.0% | 10 |
| 2010s | 51.6% | 41.0% | 64.0% | 10 |
| 2020s | 65.8% | 64.0% | 67.0% | 5 |
Countries ranked near Barbados
- 86 Dominican Republic 68.0% compare
- 86 Mauritania 68.0% compare
- 88 Iraq 67.0% compare
- 88 Jordan 67.0% compare
- 91 Algeria 65.0% compare
- 91 Costa Rica 65.0% compare
- 91 Malaysia 65.0% compare
- 91 Montenegro 65.0% compare
More gender data for Barbados
- Child population (UN estimates and projections) 46.7 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.6214 % change on previous year (2030)
- Population 235.79 (2030)
- Working-age population (UN estimates and projections) 235.79 (2030)
- Population (UN estimates and projections), annual growth rate 0.0373 % change on previous year (2030)
- Age population, age 00, female, interpolated 1,526 (2025)
- Age population, age 00, male, interpolated 1,574 (2025)
- Age population, age 01, female, interpolated 1,531 (2025)
- Age population, age 01, male, interpolated 1,581 (2025)
- Age population, age 02, female, interpolated 1,539 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Barbados?
- Access to anti-retroviral drugs, female in Barbados was 67.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Barbados?
- The highest recorded value was 67.0% in 2021.
- What is the lowest access to anti-retroviral drugs, female recorded in Barbados?
- The lowest recorded value was 0.0% in 2000.
- How does Barbados rank for access to anti-retroviral drugs, female?
- Barbados ranks 88th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Barbados?
- Over the last ten years it is up 34.0%. The long-run trend across the full record is rising.
- Where does this Barbados data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.